Today's Daily Dose brings you news about the progress in Flexion Therapeutics' pipeline; Immunome's coronavirus research program; Pfizer/BioNTech testing COVID-19 vaccine in pregnant women; and Rigel's deal with Lilly to develop RIPK1 inhibitors.
Eli Lilly And Co (NYSE: LLY) announced a licensing deal Thursday with smaller biopharma Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) that helps Lilly ...
Rigel Pharmaceuticals Inc. shares undefined soared 39% in premarket trade Thursday, after the company said it has agreed to partner with Eli Lilly and Co....
Today we’re going to discuss the secret to double-digit annual returns every year, forever, with secure dividend stocks.
It’s simple but not easy. Here’s...
February 12, 2021 (Investorideas.com Newswire) Shares of AC Immune SA traded 15% higher after the firm reported that interim results from the Phase 1b/2a Alzhei...
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Feb. 10) 9 ...
Pre-open movers
U.S. stock futures traded higher in early pre-market trade after closing slightly lower in the previous session. Bitcoin prices traded lower ...